Post-metastasis survival in extremity soft tissue sarcoma: A recursive partitioning analysis of prognostic factors

被引:36
|
作者
Kang, Seungcheol [1 ,2 ]
Kim, Han-Soo [1 ,2 ]
Kim, SungJu [3 ]
Kim, Wanlim [1 ,2 ]
Han, Ilkyu [1 ,2 ]
机构
[1] Seoul Natl Univ Hosp, Dept Orthopaed Surg, Seoul 110744, South Korea
[2] Seoul Natl Univ, Canc Hosp, Musculoskeletal Tumor Ctr, Seoul 110744, South Korea
[3] Korea Univ, Dept Stat, Seoul 136701, South Korea
关键词
Soft tissue sarcoma; Extremity; Metastasis; Survival; Recursive partitioning analysis; Grade; Metastasectomy; Disease free interval; LYMPH-NODE METASTASIS; PULMONARY METASTASES; CANCER; CHEMOTHERAPY;
D O I
10.1016/j.ejca.2014.03.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Recursive partitioning analysis (RPA) enables grouping of patients into homogeneous prognostic groups in a visually intuitive form and has the capacity to account for complex interactions among prognostic variables. In this study, we employed RPA to generate a prognostic model for extremity soft tissue sarcoma (STS) patients with metastatic disease. Methods: A retrospective review was conducted on 135 patients with metastatic STS who had undergone surgical removal of their primary tumours. Patient and tumour variables along with the performance of metastasectomy were analysed for possible prognostic effect on post-metastatic survival. Significant prognostic factors on multivariate analysis were incorporated into RPA to build regression trees for the prediction of post-metastatic survival. Results: RPA identified six terminal nodes based on histological grade, performance of metastasectomy and disease-free interval (DFI). Based on the median survival time of the terminal nodes, four prognostic groups with significantly different post-metastatic survival were generated: (1) group A: low grade/metastasectomy; (2) group B: low grade/no metastasectomy/DFI >= 12 months or high grade/metastasectomy; (3) group C: low grade/no metastasectomy/ DFI < 12 months or high grade/no metastasectomy/DFI P 12 months; and (4) group D: high grade/no metastasectomy/DFI < 12 months. The 3-year survival rates for each group were: group A, 76.1 +/- 9.6%; group B, 42.3 +/- 10.3%; group C, 18.8 +/- 8.0%; and group D, 0.0 +/- 0.0%. Conclusion: Our prognostic model using RPA successfully divides STS patients with metastasis into groups that can be easily implemented using standard clinical parameters. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1649 / 1656
页数:8
相关论文
共 50 条
  • [21] Recursive Partitioning Analysis (RPA) of Prognostic Factors for Overall Survival in Patients with Spinal Metastasis: A New System for Stratified Treatment
    Yang, Xiong-gang
    Wang, Feng
    Feng, Jiang-tao
    Hu, Yong-cheng
    Lun, Deng-xing
    Hua, Kun-chi
    Liu, Yong-heng
    Zhang, Hao
    Yang, Li
    WORLD NEUROSURGERY, 2019, 127 : E124 - E131
  • [22] Performance of PERSARC as Prognostic Tool of Extremity Soft Tissue Sarcoma
    So, C. P.
    Jayasankar, V.
    Mahendra, A.
    BRITISH JOURNAL OF SURGERY, 2023, 110
  • [23] Haemorrhagic soft-tissue sarcoma: Oncological outcomes and prognostic factors for survival
    Maes, Danielle J.
    Alaqeel, Motaz
    Parry, Michael
    Botchu, Rajesh
    Sumathi, Vaiyapuri
    Jeys, Lee M.
    Stevenson, Jonathan D.
    EJSO, 2023, 49 (02): : 345 - 352
  • [24] PROGNOSTIC FACTORS PREDICTIVE OF SURVIVAL FOR TRUNCAL AND RETROPERITONEAL SOFT-TISSUE SARCOMA
    SINGER, S
    CORSON, JM
    DEMETRI, GD
    HEALEY, EA
    MARCUS, K
    EBERLEIN, TJ
    ANNALS OF SURGERY, 1995, 221 (02) : 185 - 195
  • [25] Prognostic factors predictive of survival for retroperitoneal soft-tissue sarcoma in The Netherlands
    vanDalen, T
    Hennipman, AH
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 486 - 486
  • [26] Primary and recurrent retroperitoneal soft tissue sarcoma: Prognostic factors affecting survival
    Chiappa, A
    Zbar, AP
    Bertani, E
    Biffi, R
    Luca, F
    Crotti, C
    Testori, A
    Lazzaro, G
    De Pas, T
    Ugo, P
    Andreoni, B
    JOURNAL OF SURGICAL ONCOLOGY, 2006, 93 (06) : 456 - 463
  • [27] Prognostic factors for post-progression survival after trabectedin treatment in patients with advanced soft tissue sarcoma
    Iwata, S.
    Yonemori, K.
    Arakawa, A.
    Maejima, A.
    Nakatani, F.
    Kobayashi, E.
    Mori, T.
    Sudo, K.
    Noguchi, E.
    Hirose, T.
    Komatsubara, S.
    Fujimoto, H.
    Ogawa, C.
    Tamura, K.
    Kawai, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [28] PROGNOSTIC FACTORS IN SOFT-TISSUE SARCOMA
    WESTBURY, G
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1992, 74 (04): : 486 - 487
  • [29] Staging and prognostic factors in soft tissue sarcoma
    Pisters, PWT
    Pollock, RE
    SEMINARS IN RADIATION ONCOLOGY, 1999, 9 (04) : 307 - 314
  • [30] Socioeconomic Disparities in the Treatment and Survival of Extremity Soft Tissue Sarcoma
    Dunlop, Hayley M.
    Bende, Bence
    Kim, Alex
    Fisher, James
    Grignol, Valerie
    Contreras, Carlo M.
    Obeng-, Samilia
    Pawlik, Timothy
    Mayerson, Joel
    Pollock, Raphael
    Beane, Joal D.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S26 - S26